BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24752453)

  • 21. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
    Al-Baqsami ZF; Ahmad S; Khan Z
    Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.
    Khadka S; Sherchand JB; Pokhrel BM; Parajuli K; Mishra SK; Sharma S; Shah N; Kattel HP; Dhital S; Khatiwada S; Parajuli N; Pradhan M; Rijal BP
    BMC Res Notes; 2017 Jun; 10(1):218. PubMed ID: 28646915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
    Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
    Kamikawa Y; Mori Y; Nagayama T; Fujisaki J; Hirabayashi D; Sakamoto R; Hamada T; Sugihara K
    BMC Oral Health; 2014 Feb; 14():14. PubMed ID: 24552136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated Cutaneous Granuloma Caused by Candida glabrata: A Rare Case Report and Literature Review.
    Fan Y; Pan W; Wang G; Huang Y; Li Y; Fang W; Tao X
    Mycopathologia; 2018 Apr; 183(2):417-421. PubMed ID: 29164434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent arthritis caused by Candida parapsilosis: a case report and literature review.
    Fang H; Huang L; Zhang R; Xie D; Sun H; Zeng C; Cai D
    BMC Infect Dis; 2019 Jul; 19(1):631. PubMed ID: 31315565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida glabrata's recurrent infections: biofilm formation during Amphotericin B treatment.
    Rodrigues CF; Silva S; Azeredo J; Henriques M
    Lett Appl Microbiol; 2016 Aug; 63(2):77-81. PubMed ID: 27259377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation.
    Redding SW; Kirkpatrick WR; Saville S; Coco BJ; White W; Fothergill A; Rinaldi M; Eng T; Patterson TF; Lopez-Ribot J
    J Clin Microbiol; 2003 Feb; 41(2):619-22. PubMed ID: 12574256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
    Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
    Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Don't mess with the machine - evaluation of fluconazole susceptibility testing for Candida glabrata using the new VITEK2 AST-YS08 card following species modification.
    Korem M; Geffen Y; Amit S
    Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114896. PubMed ID: 31780195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
    González GM; Elizondo M; Ayala J
    J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
    Lye DC; Hughes A; O'Brien D; Athan E
    Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):753-5. PubMed ID: 16283214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Barton R; Bijie H; Bille J; Chang SC; da Luz Martins M; Duse A; Dzierzanowska D; Ellis D; Finquelievich J; Gould I; Gur D; Hoosen A; Lee K; Mallatova N; Mallie M; Peng NG; Petrikos G; Santiago A; Trupl J; VanDen Abeele AM; Wadula J; Zaidi M;
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in genotype and fluconazole susceptibility of isolates from patients with Candida glabrata in Tunisia.
    Abbes S; Amouri I; Sellami H; Neji S; Trabelsi H; Cheikhrouhou F; Makni F; Ranque S; Ayadi A
    Therapie; 2014; 69(5):449-55. PubMed ID: 25285365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotyping of clinical isolates of Candida glabrata from Iran by multilocus sequence typing and determination of population structure and drug resistance profile.
    Amanloo S; Shams-Ghahfarokhi M; Ghahri M; Razzaghi-Abyaneh M
    Med Mycol; 2018 Feb; 56(2):207-215. PubMed ID: 28482076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for
    Wright WF; Bejou N; Shields RK; Marr K; McCarty TP; Pappas PG
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31345844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low Level of Antifungal Resistance in Iranian Isolates of Candida glabrata Recovered from Blood Samples in a Multicenter Study from 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of
    Arastehfar A; Daneshnia F; Zomorodian K; Najafzadeh MJ; Khodavaisy S; Zarrinfar H; Hagen F; Zare Shahrabadi Z; Lackner M; Mirhendi H; Salehi M; Roudbary M; Pan W; Kostrzewa M; Boekhout T
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30936110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.